Dinsmore Christopher
Chief Scientific Officer at Kronos Bio, Inc.
- Sold, on record
- $783k
- Dollars the filings state
- Form 4 sales
- 9
- Latest Jan 4, 2024
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Kronos Bio, Inc.Chief Scientific Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Kronos Bio, Inc.Plan not statedSep 7, 2021 2021
Sold 9,189 shares at $21.91 ($201k)
Dinsmore Christopher, Chief Scientific Officer
Sold 8.7% of holdings ($2.3M position)96,360 shares leftFiling
- 2 Form 4 sale Kronos Bio, Inc.Plan not statedOct 4, 2021 +27 days
Sold 9,189 shares at $20.81 ($191k)
Dinsmore Christopher, Chief Scientific Officer
Sold 8.7% of holdings ($2.2M position)96,360 shares leftFiling
- 3 Form 4 sale Kronos Bio, Inc.Plan not statedDec 13, 2021 +70 days
Sold 11,386 shares at $12.37 ($141k)
Dinsmore Christopher, Chief Scientific Officer
Sold 11.8% of holdings ($1.2M position)84,974 shares left1.2x usual sizeFiling
- 4 Form 4 sale Kronos Bio, Inc.Plan not statedDec 12, 2022 +364 days
Sold 9,138 shares at $1.81 ($17k)
Dinsmore Christopher, Chief Scientific Officer
Sold 5.3% of holdings ($311k position)162,936 shares left1x usual sizeFiling
- 5 Form 4 sale Kronos Bio, Inc.Plan not statedFeb 24, 2023 +74 days
Sold 6,291 shares at $1.74 ($11k)
Dinsmore Christopher, Chief Scientific Officer
Sold 2.2% of holdings ($507k position)285,001 shares left0.7x usual sizeFiling
- 6 Form 4 sale Kronos Bio, Inc.No planJul 6, 2023 +132 days
Sold 6,634 shares at $1.75 ($12k)
Dinsmore Christopher, Chief Scientific Officer
No 10b5-1 planSold 2.3% of holdings ($499k position)278,367 shares left0.7x usual sizeFiling
- 7 Form 4 sale Kronos Bio, Inc.No planDec 12, 2023 +159 days
Sold 10,032 shares at $1.31 ($13k)
Dinsmore Christopher, Chief Scientific Officer
No 10b5-1 planSold 3.6% of holdings ($365k position)268,335 shares left1.3x usual sizeFiling
- 8 Form 4 sale Kronos Bio, Inc.No planJan 4, 2024 +23 days
Sold 7,366 shares at $1.18 ($9k)
Dinsmore Christopher, Chief Scientific Officer
No 10b5-1 planSold 2.7% of holdings ($317k position)260,969 shares left0.9x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (9)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 4, 2024 | Jan 5, 2024 | Kronos Bio, Inc. | Chief Scientific Officer | Form 4 sale | 7,366 | $9k | 2.7% | No plan | SEC |
| Dec 12, 2023 | Dec 13, 2023 | Kronos Bio, Inc. | Chief Scientific Officer | Form 4 sale | 10,032 | $13k | 3.6% | No plan | SEC |
| Jul 6, 2023 | Jul 7, 2023 | Kronos Bio, Inc. | Chief Scientific Officer | Form 4 sale | 6,634 | $12k | 2.3% | No plan | SEC |
| Feb 24, 2023 | Feb 24, 2023 | Kronos Bio, Inc. | Chief Scientific Officer | Form 4 sale | 6,291 | $11k | 2.2% | Plan not stated | SEC |
| Dec 12, 2022 | Dec 14, 2022 | Kronos Bio, Inc. | Chief Scientific Officer | Form 4 sale | 9,138 | $17k | 5.3% | Plan not stated | SEC |
| Dec 13, 2021 | Dec 15, 2021 | Kronos Bio, Inc. | Chief Scientific Officer | Form 4 sale | 11,386 | $141k | 11.8% | Plan not stated | SEC |
| Oct 4, 2021 | Oct 4, 2021 | Kronos Bio, Inc. | Chief Scientific Officer | Form 4 sale | 9,189 | $191k | 8.7% | Plan not stated | SEC |
| Sep 7, 2021 | Sep 9, 2021 | Kronos Bio, Inc. | Chief Scientific Officer | Form 4 sale | 9,189 | $201k | 8.7% | Plan not stated | SEC |
| Aug 2, 2021 | Aug 3, 2021 | Kronos Bio, Inc. | Chief Scientific Officer | Form 4 sale | 9,189 | $189k | 8.7% | Plan not stated | SEC |